Glucagon-like peptide 1 (but not gastric inhibitory peptide) increased 1.5 to 2 times in fibrocalculous pancreatic diabetes as compared with T2DM and controls (fasting and post glucose), without differences in dipeptidyl peptidase IV [38]. The gene discussed is GCG; the disease is type 2 diabetes mellitus.